Clinical therapy of schistosomiasis mansoni: The Brazilian contribution

Acta Tropica

Volumn 108, Issue 2-3, 2008, Pages 72-78

  Katz, N ^a,b   Coelho, P M Z ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Santa Casa de Belo Horizonte   (Brazil)

Author keywords

Antischistosomal chemotherapy; Drug resistance; Review; Schistosomiasis mansoni

Indexed keywords

1,2,3,4 TETRAHYDRO 2 ISOPROPYLAMINOMETHYL 6 METHYL 7 NITROQUINOLINE; ANTIMONY GLUCONATE; ANTIMONY TARTRATE; BILLTRICIDE; CISTICIDE; HYCANTHONE; HYCANTHONE METHANESULFONATE; LUCANTHONE; NIRIDAZOLE; OXAMNIQUINE; PRAZIQUANTEL; QUINOLINE DERIVATIVE; SODIUM ANTIMONYL THIOMELATE; STIBOCAPTATE; STIBOFEN; STIBOPHEN; TRIOSTAN; UNCLASSIFIED DRUG;

CHEMOTHERAPY; DISEASE TREATMENT; DRUG DEVELOPMENT; DRUG RESISTANCE;

ABDOMINAL PAIN; ANOREXIA; BRAZIL; CARCINOGENICITY; CONVULSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG ACTIVITY; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESISTANCE; DRUG TOLERABILITY; EMBRYOTOXICITY; FECES ANALYSIS; FEVER; HALLUCINATION; HEADACHE; HEPATOSPLENOMEGALY; HISTORY OF MEDICINE; HUMAN; JAPAN; LIVER CIRRHOSIS; LIVER FATTY DEGENERATION; MORBIDITY; MUTAGENICITY; NAUSEA; NONHUMAN; PHILIPPINES; PRURITUS; RECTUM BIOPSY; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMICIDAL ACTIVITY; SINGLE DRUG DOSE; VOMITING; WAR;

ANIMALS; ANTHELMINTICS; BRAZIL; DRUG RESISTANCE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

BRAZIL; SOUTH AMERICA;

EID: 56949094113     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.05.006     Document Type: Review

References (89)

1. Amaral, R., 2006. Personal communication.
2. Andrade Z.A., Santos H.A., Borojovic B., and Grimaud J. Lesões hepáticas produzidas por hycanthone. Rev. Inst. Med. Trop. São Paulo 16 (1974) 160-170
3. Andrade Z.A., Santos H.A., and Grimaud J.A. The liver after oxamniquine treatment of schistosomiasis. Rev. Inst. Med. Trop. São Paulo 22 Suppl. 4 (1980) 37-40
4. Andrews P., Thomas H., Pohlke R., and Seuber J. Praziquantel. Med. Res. Rev. 3 (1983) 147-200
5. Baxter C.A.R., and Richards H.C. Schistosomicides. 1. Derivatives of 2-aminomethyl-1,2,3,4-tetrahydroquinoline. J. Med. Chem. 14 (1971) 1033-1042
6. Bina J.C. Influência da terapêutica específica na evolução da esquistossomose mansoni (1977), Tese, Universidade Federal da Bahia, Salvador, Brazil
7. Bogliolo, L., 1959. Patologia. Separata da Revista Brasileira de Malariologia e Doenças Tropicais, n°s 2 e 3 (XI).
8. Brener Z. Quimioterapia da esquistossomose experimental. II. Observações sobre a atividade terapêutica do cloridrato de glucosamina. Hospital 57 (1960) 1069-1073
9. Cançado J.R., da Cunha A.S., Carvalho D.G., and Cambraia J.N.S. Evaluation of the treatment of human Schistosoma mansoni infection by the quantitative oogram technique. Bull. World Health Org. 33 (1965) 557-566
10. Christopherson J.B. The successful use of antimony in bilharziosis. Administered as intravenous injections of antimonium tartaratum (tartar emetic). Lancet II (1918) 325-327
11. Cioli D., Pica-Mattoccia L., and Archer S. Antischistosomal. drugs: past, present and future. Pharmacol. Ther. 68 (1995) 35-85
12. Cioli D., Botros S.S., Wheatcroft-Francklow K., Mbaye A., Southgate V., Tchuenté L.A.T., Pica-Mattoccia L., Troiani A.R., Seif el-Din S.H., Sabra A.N.A., Albin J., Engels D., and Doenhoff M.J. Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates. Int. J. Parasitol. 34 (2004) 979-987
13. Coelho P.M.Z., Mello R.T., and Gerken S.E. Schistosoma mansoni: evaluation of the activity of oxamniquine on schistosomules, at 24 h after infection. Rev. Inst. Med. Trop. São Paulo 15 (1993) 557-561
14. Coelho P.M.Z., Ribeiro F., Mello R.T., Lima e Silva F.C., and Nogueira-Machado J.A. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase. Mem. Inst. Oswaldo Cruz 93 (1998) 267-268
15. Coelho R.B. Introdução ao estudo da patologia da esquistossomose mansonica. J. Br. Med. 8 3 (1964) 279-283
16. Conceição M.J., Argento C.A., and Correa A. Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine. Mem. Inst. Oswaldo Cruz 95 (2000) 375-380
17. Coura J.R., Argento C.A., Conceição M.J., Lewis E.M., Santos M.L., and Magalhães P. Experiências de campo com oxamniquine oral no tratamento da esquistossomose mansoni. Rev. Inst. Med. Trop. São Paulo 22 Suppl. 4 (1980) 195-202
18. Coura J.R., Conceição M.J., Menezes A.P., Santos M.L., and Mendonça M.Z.G. Morbidade da esquistossomose no Brazil. II. Estudo em quatro áreas de campo nos estados de Minas Gerais, Sergipe e Paraíba. Mem. Inst. Oswaldo Cruz 78 (1983) 1-11
19. Coutinho A., and Dominguez A.L.C. Evaluation of the treatment of severe forms of schistosomiasis mansoni with oxamniquine. Rev. Inst. Med. Trop. São Paulo 22 Suppl. 4 (1980) 41-51
20. Coutinho A.D., Domingues A.L.C., Florêncio J.N., and Almeida S.T. Tratamento da esquistossomose hepato-esplênica com praziquantel. Rev. Inst. Med. Trop. São Paulo 26 (1984) 38-50
21. Coutinho A.B. Patologia geral da esquistossomose. Rev. Br. Gastroenterol. Rio de Janeiro 9 (1957) 5-18
22. Cunha A.S., and Cançado J.R. Avaliação terapêutica da WIN 24.933-2 (derivado hidroximetil do miracil D) e do A 16. 612 (composto de piperazina) na esquistossomose mansoni humana pelo método de oograma quantitative. Rev. Inst. Med. Trop. São Paulo 10 2 (1968) 118-123
23. Davis A., and Wegner D.H. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull. World Health Org. 57 (1979) 767-771
24. Dias, C.B., 1949. Quimioterapia antimonial na esquistossomose mansônica. Tese, Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
25. Dias L.C.S., Pedro R.J., and Debelardini E.R. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents. Trans. R. Soc. Trop. Med. Hyg. 76 (1982) 652-659
26. Domingues A.L., and Coutinho A. Tratamento da esquistossomose mansoni com oxaminquine oral. Rev. Inst. Med. Trop. São Paulo 17 (1975) 164-180
27. El Sayed M.K., Barakat R., Farghaly A., El Badway A., Soliman N.K., Husein M.H., and Miller F.D. The impact of passive chemotherapy on Schistosoma mansoni prevalence and intensity of infection in the Egyptian Nile Delta. Am. J. Trop. Med. Hyg. 57 (1997) 266-271
28. Enk M.J., Katz N., and Coelho P.M.Z. A case of Schistosoma mansoni infection treated during the pre-patent period. Nat. Clin. Pract. Gastroenterol. Hepathol. 5 (2008) 112-115
29. Farley J. Bilharzia: A History of Imperial Tropical Medicine (1991), Press Syndicate of the University of Cambridge, England
30. Fenwick A., Savioli L., Engels D., Berequist R.N., and Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 19 (2003) 509-515
31. Ferrari M.L.A., Coelho P.M.Z., Antunes C.M.F., Tavares C.A.P., and Cunha A.S. Efficacy of oxamniquine and praziquantel in schistosomiasis mansoni treatment: a controlled trial. Bull. World Health Org. 81 (2003) 190-196
32. Foster R. The preclinical development of oxamniquine. Rev. Inst. Med. Trop. São Paulo 15 (1973) 1-9
33. Foster R., Cheetham B.I., King D.F., and Mesmer E.T. The action of UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative, against mature schistosomes in rodents and primates. Ann. Trop. Med. Parasitol. 65 (1971) 59-70
34. Foster R., Cheetham B.L., and King D.F. Studies with the schistosomicide oxamniquine (UK-4271). II. Activity in primates. Trans. R. Soc. Trop. Med. Hyg. 67 (1973) 685-693
35. Foster R., Mesmer E.T., Cheetham B.L., and King D.F. The control of immature Schistosoma mansoni in mice by UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative. Ann. Trop. Med. Parasitol. 65 (1971) 221-232
36. Greenberg C. Are Ca2+ channels targets of praziquantel action?. Int. J. Parasitol. 35 (2005) 1-9
37. Gryseels B., Stelma F.F., Talla I., Van Dam G.J., Polman K., Sow S., Diaw M., Sturrock R.F., Doehring-Schwerdtfeger E., Kardorff R., Decamic, Niang M., and Deelder A.M. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop. Geogr. Med. 46 (1994) 209-219
38. Homeida M.A., El Tom I., Nash T., and Bennett J.L. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. Am. J. Trop. Med. Hyg. 45 (1991) 360-365
39. Ishizaki T., Kamo E., and Boehme K. Double-blind studies on tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections. Bull. World Health Org. 57 (1979) 787-791
40. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., Day T.A., and Bennett J.L. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60 (1999) 932-935
41. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L.F., and Bennett J.L. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg. 55 (1996) 214-218
42. Katz N., Chaves A., and Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. São Paulo 14 (1972) 397-402
43. Katz N., Dias E.P., and Araújo N. Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas. Rev. Soc. Br. Med. Trop. 7 (1973) 381-387
44. Katz N., Grinbaum E., Chaves A., Zicker F., and Pellegrino J. Clinical trials with oxamniquine, by oral route, in schistosomiasis mansoni. Rev. Inst. Med. Trop. São Paulo 18 (1976) 371-377
45. Katz N., and Pellegrino J. Studies of various aspects of schistosomiasis mansoni in Cebus monkeys using the quantitative oogram method. Rev. Inst. Med. Trop. São Paulo 16 (1974) 245-252
46. Katz N., Pellegrino J., and Memoria J.M. Quantitative oogram method in Cebus monkeys experimentally infected with Schistosoma mansoni. J. Parasitol. 52 (1966) 917-919
47. Katz N., Rocha R.S., and Chaves A. Preliminary trials with praziquantel in human infections due to Schistosoma mansoni. Bull. World Health Org. 57 (1979) 781-785
48. Katz N., Rocha R.S., Lambertucci J.R., Greco D.B., Pedroso E.R.P., Rocha M.O.C., and Flan S. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni. Rev. Inst. Med. Trop. São Paulo 25 (1983) 173-177
49. Katz N., Rocha R.S., and Pereira J.P. Controle da esquistossomose em Peri-Peri (Minas Gerais) através de repetidos tratamentos clínicos e aplicações de molucicidas. Rev. Inst. Med. Trop. São Paulo 22 Suppl. 4 (1980) 203-211
50. Katz N., Zicker F., and Pereira J.P. Field trials with oxamniquine in schistosomiasis mansoni in endemic areas. Am. J. Trop. Med. Hyg. 26 (1977) 234-237
51. Katz N., Rocha R.S., Lambertucci J.R., Greco D.B., Pedroso E.R.P., Rocha M.O.C., and Flan S. Clinical Trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni. Rev. Inst. Med. Trop. São Paulo 25 (1983) 173-177
52. Kaye B., and Woolhouse W.M. The metabolism of a new schistosomicide 2-isopropylaminomethyl-6-methyl-7-nitro-1,2,3,4-tetrahydroquinoline (UK 3883). Xenobiotica 2 (1972) 169-178
53. Kloetzel K. Aspectos epidemiológicos da esquistossomose mansônica em uma população de Pernambuco (1962), Tese, Universidade de São Paulo, Brazil
54. Kloetzel K. A rationale for the treatment of schistosomiasis mansoni, even when reinfection is expected. Trans. R. Soc. Trop. Med. Hyg. 61 (1967) 609-610
55. Kusel J.R., Oliveira F.A., Coelho P.M.Z., Mattos A.C.A., Reis K., Lima S.F., and Ribeiro F. The effects of íons, poly-l-lysine and praziquantel on the excretory system of Schistosoma mansoni. Mem. Inst. Oswaldo Cruz 101 (2006) 293-298
56. Lambertucci J.R. Acute schistosomiasis: clinical, diagnostic and therapeutic features. Rev. Inst. Med. Trop. São Paulo 35 (1993) 399-404
57. Lima e Costa M.F., Guerra H.L., Pimenta-Júnior F.G., Firmo J.O., and Uchoa E. Avaliação do Programa de controle da esquistossomose (PCE/PCDEN) em municípios situados na Bacia do Rio São Francisco, Minas Gerais, Brazil. Rev. Soc. Br. Med. Trop. 29 (1996) 117-126
58. Maciel H. Tratamento intensivo das esquistossomoses. Rev. Br. Med. Rio de Janeiro 6 7 (1949) 491-492
59. Meira J.A. Quadro clínico da esquistossomose mansonica. Rev. Br. Malariol. D. Trop. Rio de Janeiro 11 (1959) 247-357
60. Modha J., Lambertucci J.R., Doenhoff M.J., and McLaren D.J. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo. Parasite Immunol. 12 (1990) 321-334
61. Oliveira F.A., Kusel J.R., Ribeiro F., and Coelho P.M.Z. Response of the surface membrane and excretory system of Schistosoma mansoni damage and to treatment with praziquantel and other biomelecules. Parasitology 132 (2006) 321-330
62. Ottolina C., and Atencio H.M. Nuevos caminos para el diagnóstico clínico preciso de la schistosomiasis mansoni. Rev. Pol. Caracas 12 (1943) 1-35
63. PECE (Programa Especial de Controle da Esquistossomose no Brazil), 1976. Publicação do Conselho de Desenvolvimento Nacional, Brasília, Brazil, 41.
64. Pedro R.J., Dias L.C.S., Amato Neto V., and Carvalho A.S. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects. Rev. Inst. Med. Trop. São Paulo 22 Suppl. 4 (1980) 32-36
65. Pellegrino J., and Katz N. Experimental chemotherapy of schistosomiasis mansoni. Adv. Parasitol. 6 (1968) 233-290
66. Pellegrino J., Katz N., and Dias E.P. Experimental chemotherapy of schistosomiasis. VII. Laboratory trials with oxamniquine, a new antischistosomal agent. Rev. Inst. Trop. São Paulo 15 Suppl. 1 (1973) 10-14
67. Pellegrino J., Oliveira C.A., Faria J., and Cunha A.S. New approach to the screening of drugs in experimental Schistosoma mansoni in mice. Am. J. Top. Med. Hyg. 11 (1962) 201-215
68. Pellegrino J., Katz N., Oliveira C.A., and e Okabe K. Rectal biopsy and mucosal curettage in Cebus monkeys experimentally infected with Schistosoma mansoni and Schistosoma japonicum. J. Parasitol. 51 (1965) 617-621
69. Picca-Mattocia L., Valle C., Basso A., Traiani A.R., Vigorosi F., Liberti P., Fetucci A., and Cioli D. Cystochalisin D abolishes the schistosomicidal activity of praziquantel. Exp. Parasitol. 115 (2007) 344-351
70. Prata, A., 1957. Biopsia retal na esquistossomose mansoni. Bases e aplicações no diagnóstico e tratamento. Tese de Doutorado, Serviço Nacional de Educação Sanitária, 1-197.
71. Prata A., Bina J.C., Barreto A.C., and Alecrim M.G. Ensaio de controle da transmissão da esquistossomose pela oxamniquine, em uma localidade hiperendêmica. Rev. Inst. Med. Trop. São Paulo 22 Suppl. 4 (1980) 182-189
72. Rabello A., Garcia M.M.A., Pinto da Silva R.A., Rocha R.S., and Katz N. Humoral immune responses in patients with acute Schistosoma mansoni infection who were followed up to two years after treatment. Clin. Infec. Dis. 24 (1997) 304-308
73. Revista do Instituto de Medicina Tropical de São Paulo, 1980. Vol. 22 (Suppl. 4), 1-116.
74. Revista do Instituto de Medicina Tropical de São Paulo, 1973. Vol. 15 (Suppl. 1), 1-88.
75. Rezende G.L. Survey on the clinical trial results achieved in Brazil comparing praziquantel and oxamniquine in the treatment of mansoni schistosomiasis. Rev. Inst. Med. Trop. São Paulo 27 (1985) 328-336
76. Ribeiro F., Coelho P.M.Z., Vieira L.Q., Watson D.G., and Kusel J.R. The effect of praziquantel treatment on glutathione concentration in Schistosoma mansoni. Parasitology 116 (1998) 229-236
77. Ribeiro F., Tavares C.A.P., Teixeira R., Kusel J.R., and Coelho P.M.Z. Synergistic action of praziquantel and host specific immune response against Schistosoma mansoni at different phases of infection. Rev. Inst. Med. Trop. São Paulo 46 (2004) 231-236
78. Richards H.C., and Foster R. A new series of 2-aminomethyltetrahydroquinoline derivatives displaying schistosomicidal activity in rodents and primates. Nature 222 (1969) 581-582
79. Richter J. The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop. 86 (2003) 161-183
80. Round Table about Ambilhar, 1966. Mesa Redonda sobre CIBA 32,644-Ba (Ambilhar), Folha Médica 53, 21-151.
81. Santos A.T., Blas B.L., Noseñas J.S., Portillo G.P., Ortega O.M., Hayashi M., and Boehme K. Preliminary clinical trials with praziquantel in Schistosoma japonicum infections in the Philippines. Bull. World Health Org. 57 (1979) 793-799
82. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin A.P., and Williams D.C. Identification of oxidiazoles, as new drug leads for the control of schistosomiasis. Nat. Med. 16 (2008) 1-6
83. Sette, H., 1953. O tratamento da esquistossomose à luz da patologia hepática (estudo clínico). Tese, Faculdade Nacional de Medicina, Rio de Janeiro, RJ, Brazil.
84. Silva L.C., Sette J.R.H., Chamone D.A.F., Alquezar A.S., Punskas J.A., and Raia S. Clinical trials with oral oxamniquine (UK 4271) for the treatment of mansoni schistosomiasis. Rev. Inst. Med. Trop. São Paulo 16 (1974) 103-109
85. Silva J.R. Aspectos básicos relativos a terapêutica específica na esquistossomose mansoni (Estudo de revisão com referência especialmente a quimioterapia antimonial por via parenteral). Rev. Br. Malariol. D. Trop. 9 (1957) 417-435
86. Silva J.R. O miracil D no tratamento da esquistossomose mansonica. Rev. Br. Méd. 9 8 (1952) 577-581
87. Utzinger J., N'Goran E.K., N'Dri A., Lengeler C., Shuhua X., and Tammer M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355 (2000) 1320-1325
88. Xiao S.H., Tanner M., N'Goran E.K., Utzinger J., Chollet J., Bergquist R., Chen M.G., and Zeng J. Recent investigation of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop. 82 (2002) 175-181
89. World Health Organization, 1985. Schistosomiasis Control. Tech. Report Ser. 728.